2Rath W. A clinical evaluation of controlled-release dinoprostone for cervical ripening-a review of current evidence in hospital and outpatient settings [J] . J Perinat Med, 2005, 33 (6) : 491-499.
3乐杰.妇产科学[M]北京:人民卫生出版社,2004.
4刘云嵘;孙爱军.药物终止妊娠的方法[M]北京:人民卫生出版社,199918.
5怀玉美.米索前列醇在足月妊娠中的临床应用[J]中华医学实践杂志,2007(05):65.
6von Hertzen H,Piaggio G,Wojdyla D,et al.Two mifepristonedoses and twointervals of misoprostol administration for termina-tion of early pregnan-cy:a randomized factorial controlled equiv—alence trial [J]. BJOG,2(X)9(8):696-754.
7Gilbert A,Reid R.A randomised trial of oral versus vaginaladministration ofmisoprostol for the purpose of mid-trimester termination of pregnancy [J].Australian and New Zealand Journal of Obstetrics and Gynaecology, 2001(18):1375-1448.
8Tran NT,Jang MC,Choe YS,et al.Feasibility,efficacy,safe -ty,and accept-ability of mifepristone -misoprostol for medicalabortioninthe DemocraticPeople's Republic of Korea [J].International Journal of Gynecology andObstetrics ,2010(12); 158-201.
9M Fjerstad,I Sivin,ES Lichtenberg,et al.Effectiveness of medical abortionwith mifepristone and buccal misoprostol through 59 gestational day [J].Contraception,2009(6):663-691.
10Vaisanen-Tommiska M,Butzow R et al.Mifepristone—induced nitric oxiderelease and expression of nitric oxide synthases in the human cervix dur-ing early pregnancy[J].Human Reproduction, 2006(10):818-886.
